ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「運動とアルツハイマー病予防─効果が見られる時期に「窓」がある可能性」の検索結果

785 件中 10 件を表示 (5167 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
(exercise OR "physical activity" OR "motor activity"[MeSH]) AND ("Alzheimer Disease"[MeSH] OR "Alzheimer's disease") AND (prevention OR prophylaxis) AND ("critical period" OR "time window" OR timing OR "sensitive period" OR age OR lifespan)

💡 運動とアルツハイマー予防の関連に加え、効果的な介入時期やクリティカルピリオドの概念を含めました

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Neuroprotective mechanisms of exercise and the importance of fitness for healthy brain ageing.

    Atefe R Tari, Tara L Walker, Aleksi M Huuha 他 · Lancet (London, England) · 2025

    Ageing is a scientifically fascinating and complex biological occurrence characterised by morphological and functional changes due to accumulated molecular and cellular damage impairing tissue and organ function. Ageing is often accompanied by cognitive decline but is also the biggest known risk factor for Alzheimer's disease, the most common form of dementia. Emerging evidence suggests that seden…

    📄 PubMed で読む (PMID: 40157803)
  • An overview of the genes and biomarkers in Alzheimer's disease.

    Hari Krishnan Krishnamurthy, Vasanth Jayaraman, Karthik Krishna 他 · Ageing research reviews · 2025

    Alzheimer's disease (AD) is the most common type of dementia and neurodegenerative disease characterized by neurofibrillary tangles (NFTs) and amyloid plaque. Familial AD is caused by mutations in the APP, PSEN1, and PSEN2 genes and these mutations result in the early onset of the disease. Sporadic AD usually affects older adults over the age of 65 years and is, therefore classified as late-onset …

    📄 PubMed で読む (PMID: 39612989)
  • Exercise and dementia prevention.

    Jane Alty, Maree Farrow, Katherine Lawler 他 · Practical neurology · 2020

    Ageing, genetic, medical and lifestyle factors contribute to the risk of Alzheimer's disease and other dementias. Around a third of dementia cases are attributable to modifiable risk factors such as physical inactivity, smoking and hypertension. With the rising prevalence and lack of neuroprotective drugs, there is renewed focus on dementia prevention strategies across the lifespan. Neurologists e…

    📄 PubMed で読む (PMID: 31964800)
  • Physical activity as a protective factor for dementia and Alzheimer's disease: systematic review, meta-analysis and quality assessment of cohort and case-control studies.

    Paula Iso-Markku, Urho M Kujala, Keegan Knittle 他 · British journal of sports medicine · 2022

    Physical activity (PA) is associated with a decreased incidence of dementia, but much of the evidence comes from short follow-ups prone to reverse causation. This meta-analysis investigates the effect of study length on the association. A systematic review and meta-analysis. Pooled effect sizes, dose-response analysis and funnel plots were used to synthesise the results. CINAHL (last search 19 Oct…

    📄 PubMed で読む (PMID: 35301183)
  • Consequences of physical inactivity in older adults: A systematic review of reviews and meta-analyses.

    Conor Cunningham, Roger O' Sullivan, Paolo Caserotti 他 · Scandinavian journal of medicine & science in sports · 2020

    Globally, populations are ageing. Typically, physical activity levels decline and health worsens as we age; however, estimates of the impact of physical inactivity for population health often fail to specifically focus on older adults. Multiple databases were searched for systematic reviews and/or meta-analyses of longitudinal observational studies, investigating the relationship between physical …

    📄 PubMed で読む (PMID: 32020713)
  • Emerging roles of oxidative stress in brain aging and Alzheimer's disease.

    Andra Ionescu-Tucker, Carl W Cotman · Neurobiology of aging · 2021

    Reactive oxygen species (ROS) are metabolic byproducts that are necessary for physiological function but can be toxic at high levels. Levels of these oxidative stressors increase gradually throughout the lifespan, impairing mitochondrial function and damaging all parts of the body, particularly the central nervous system. Emerging evidence suggests that accumulated oxidative stress may be one of t…

    📄 PubMed で読む (PMID: 34416493)
  • Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.

    Annabelle Santos Volgman, Gatha Nair, Radmila Lyubarova 他 · Journal of the American College of Cardiology · 2022

    The prevalence of atrial fibrillation (AF) is increasing as the population ages. AF treatment-related complications also increase markedly in older adults (defined as ≥75 years of age for this review). The older AF population has a high risk of stroke, bleeding, and death. Syncope and fall-related injuries are the most common reasons for nonprescription of oral anticoagulation (OAC), and are more …

    📄 PubMed で読む (PMID: 35027110)
  • Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

    Sam Norton, Fiona E Matthews, Deborah E Barnes 他 · The Lancet. Neurology · 2014

    Recent estimates suggesting that over half of Alzheimer's disease burden worldwide might be attributed to potentially modifiable risk factors do not take into account risk-factor non-independence. We aimed to provide specific estimates of preventive potential by accounting for the association between risk factors. Using relative risks from existing meta-analyses, we estimated the population-attrib…

    📄 PubMed で読む (PMID: 25030513)
  • Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.

    Chengxuan Qiu, Miia Kivipelto, Eva von Strauss 他 · Dialogues in clinical neuroscience · 2009

    More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregivers, and society. The etiological factors, other than older age and genetic susceptibility, remain to be determined. Nevertheless, increasing evidence strongly po…

    📄 PubMed で読む (PMID: 19585947)
  • Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review.

    Jonathan Blackman, Marta Swirski, James Clynes 他 · Journal of sleep research · 2021

    Suboptimal sleep causes cognitive decline and probably accelerates Alzheimer's Disease (AD) progression. Several sleep interventions have been tested in established AD dementia cases. However early intervention is needed in the course of AD at Mild Cognitive Impairment (MCI) or mild dementia stages to help prevent decline and maintain good quality of life. This systematic review aims to summarize …

    📄 PubMed で読む (PMID: 33289311)